These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8385830)

  • 21. Treatment and prophylaxis of cytomegalovirus infection after bone marrow transplantation.
    Schmidt GM
    Recent Results Cancer Res; 1993; 132():161-74. PubMed ID: 8265858
    [No Abstract]   [Full Text] [Related]  

  • 22. [The prevention and treatment of cytomegalovirus infection after liver transplantation].
    Zheng SS; Jiang ZJ; Xu X; Liang TB; Wang WL; Shen Y; Zhang M; Lu AW
    Zhonghua Wai Ke Za Zhi; 2005 May; 43(9):584-6. PubMed ID: 15938930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unusual endoscopic findings of CMV esophagitis after liver transplantation.
    Harada N; Shimada M; Suehiro T; Soejima Y; Ninomiya M; Shiotani S; Sugimachi K
    Hepatogastroenterology; 2005; 52(64):1236-9. PubMed ID: 16001670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of ganciclovir resistance during treatment of primary cytomegalovirus infection after liver transplantation.
    Rosen HR; Benner KG; Flora KD; Rabkin JM; Orloff SL; Olyaei A; Chou S
    Transplantation; 1997 Feb; 63(3):476-8. PubMed ID: 9039944
    [No Abstract]   [Full Text] [Related]  

  • 25. Acute infection of Toxoplasma gondii and cytomegalovirus reactivation in a pediatric patient receiving liver transplant.
    Galván Ramírez ML; Castillo-de-León Y; Espinoza-Oliva M; Bojorques-Ramos MC; Rodríguez-Pérez LR; Bernal Redondo R; Cañedo-Solares I; Espinoza López L; Correa D
    Transpl Infect Dis; 2006 Dec; 8(4):233-6. PubMed ID: 17116139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Parenteral acyclovir therapy for cytomegalovirus infection after renal transplantation.
    Nunan TO; King M; Bull P; Banatvala JE; Jones NF; Hilton PJ
    Clin Nephrol; 1984 Jul; 22(1):28-31. PubMed ID: 6090044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ganciclovir for cytomegalovirus after heart transplantation.
    Winston DJ
    N Engl J Med; 1992 Sep; 327(12):891-2; author reply 892-3. PubMed ID: 1324432
    [No Abstract]   [Full Text] [Related]  

  • 28. Evidence for an immunosuppressive activity of ganciclovir.
    Scholz D; Arndt R; Meyer T
    Transplant Proc; 1994 Dec; 26(6):3253-4. PubMed ID: 7998132
    [No Abstract]   [Full Text] [Related]  

  • 29. [Prevention of cytomegalovirus infection and disease in the transplantation patient].
    Cisneros JM; Pachón J
    Enferm Infecc Microbiol Clin; 1993 Jan; 11(1):40-4. PubMed ID: 8384888
    [No Abstract]   [Full Text] [Related]  

  • 30. Ganciclovir for cytomegalovirus after heart transplantation.
    Laske A; Gallino A; Carrel T; Turina MI
    N Engl J Med; 1992 Sep; 327(12):892; author reply 892-3. PubMed ID: 1324433
    [No Abstract]   [Full Text] [Related]  

  • 31. A randomized, controlled trial comparing ganciclovir to ganciclovir plus foscarnet (each at half dose) for preemptive therapy of cytomegalovirus infection in transplant recipients.
    Mattes FM; Hainsworth EG; Geretti AM; Nebbia G; Prentice G; Potter M; Burroughs AK; Sweny P; Hassan-Walker AF; Okwuadi S; Sabin C; Amooty G; Brown VS; Grace SC; Emery VC; Griffiths PD
    J Infect Dis; 2004 Apr; 189(8):1355-61. PubMed ID: 15073671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prophylaxis and treatment of cytomegalovirus disease in recipients of solid organ transplants: current approach and future challenges.
    Puius YA; Snydman DR
    Curr Opin Infect Dis; 2007 Aug; 20(4):419-24. PubMed ID: 17609603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dynamics of cytomegalovirus replication during preemptive therapy with oral ganciclovir.
    Razonable RR; van Cruijsen H; Brown RA; Wilson JA; Harmsen WS; Wiesner RH; Smith TF; Paya CV
    J Infect Dis; 2003 Jun; 187(11):1801-8. PubMed ID: 12751039
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human beta-herpesvirus interactions in solid organ transplant recipients.
    Mendez JC; Dockrell DH; Espy MJ; Smith TF; Wilson JA; Harmsen WS; Ilstrup D; Paya CV
    J Infect Dis; 2001 Jan; 183(2):179-184. PubMed ID: 11120923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ganciclovir for treatment of renal transplant-associated primary cytomegalovirus pneumonia.
    Hecht DW; Snydman DR; Crumpacker CS; Werner BG; Heinze-Lacey B
    J Infect Dis; 1988 Jan; 157(1):187-90. PubMed ID: 2826608
    [No Abstract]   [Full Text] [Related]  

  • 36. Ganciclovir for cytomegalovirus after heart transplantation.
    Bailey TC; Trulock EP; Storch GA; Powderly WG
    N Engl J Med; 1992 Sep; 327(12):891; author reply 892-3. PubMed ID: 1324431
    [No Abstract]   [Full Text] [Related]  

  • 37. Randomized comparison of oral valacyclovir and intravenous ganciclovir for prevention of cytomegalovirus disease after allogeneic bone marrow transplantation.
    Winston DJ; Yeager AM; Chandrasekar PH; Snydman DR; Petersen FB; Territo MC;
    Clin Infect Dis; 2003 Mar; 36(6):749-58. PubMed ID: 12627359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. AIDS research "spin-off"--ganciclovir CMV prevention after liver transplantation.
    James JS
    AIDS Treat News; 1995 Jul; (no 227):6. PubMed ID: 11362621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized prospective controlled trial of oral ganciclovir versus oral valacyclovir for prophylaxis of cytomegalovirus disease after renal transplantation.
    Reischig T; Opatrny K; Bouda M; Treska V; Jindra P; Svecova M
    Transpl Int; 2002 Dec; 15(12):615-22. PubMed ID: 12478408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytomegalovirus infection, fulminant hepatitis, and liver transplantation: the sides of the triangle.
    Samuel D; Dussaix E
    Liver Transpl Surg; 1997 Sep; 3(5):547-51. PubMed ID: 9346800
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.